nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—ATP6V1A—ganglion—peripheral nervous system neoplasm	0.0183	0.157	CbGeAlD
Alendronate—PTPN4—brainstem—peripheral nervous system neoplasm	0.0161	0.138	CbGeAlD
Alendronate—PTPRS—brainstem—peripheral nervous system neoplasm	0.0138	0.118	CbGeAlD
Alendronate—ATP6V1A—trigeminal ganglion—peripheral nervous system neoplasm	0.009	0.077	CbGeAlD
Alendronate—ATP6V1A—parotid gland—peripheral nervous system neoplasm	0.00849	0.0726	CbGeAlD
Alendronate—PTPRE—cerebellum—peripheral nervous system neoplasm	0.00835	0.0715	CbGeAlD
Alendronate—ATP6V1A—brainstem—peripheral nervous system neoplasm	0.00797	0.0681	CbGeAlD
Alendronate—PTPN4—cerebellum—peripheral nervous system neoplasm	0.00795	0.068	CbGeAlD
Alendronate—PTPRS—cerebellum—peripheral nervous system neoplasm	0.00681	0.0583	CbGeAlD
Alendronate—FDPS—trigeminal ganglion—peripheral nervous system neoplasm	0.00678	0.058	CbGeAlD
Alendronate—FDPS—parotid gland—peripheral nervous system neoplasm	0.0064	0.0547	CbGeAlD
Alendronate—ATP6V1A—cerebellum—peripheral nervous system neoplasm	0.00393	0.0336	CbGeAlD
Alendronate—FDPS—cerebellum—peripheral nervous system neoplasm	0.00296	0.0253	CbGeAlD
Alendronate—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00152	0.00172	CcSEcCtD
Alendronate—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00151	0.00171	CcSEcCtD
Alendronate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00151	0.00171	CcSEcCtD
Alendronate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00151	0.00171	CcSEcCtD
Alendronate—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.0015	0.0017	CcSEcCtD
Alendronate—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.0017	CcSEcCtD
Alendronate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00149	0.00169	CcSEcCtD
Alendronate—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00147	0.00167	CcSEcCtD
Alendronate—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00147	0.00167	CcSEcCtD
Alendronate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00147	0.00166	CcSEcCtD
Alendronate—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00146	0.00165	CcSEcCtD
Alendronate—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00146	0.00165	CcSEcCtD
Alendronate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.00165	CcSEcCtD
Alendronate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00146	0.00165	CcSEcCtD
Alendronate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00164	CcSEcCtD
Alendronate—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00164	CcSEcCtD
Alendronate—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00164	CcSEcCtD
Alendronate—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00164	CcSEcCtD
Alendronate—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00164	CcSEcCtD
Alendronate—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00164	CcSEcCtD
Alendronate—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00164	CcSEcCtD
Alendronate—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00144	0.00163	CcSEcCtD
Alendronate—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00163	CcSEcCtD
Alendronate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00144	0.00163	CcSEcCtD
Alendronate—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00162	CcSEcCtD
Alendronate—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00143	0.00162	CcSEcCtD
Alendronate—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00159	CcSEcCtD
Alendronate—Myalgia—Vincristine—peripheral nervous system neoplasm	0.0014	0.00158	CcSEcCtD
Alendronate—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00158	CcSEcCtD
Alendronate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00156	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.00155	CcSEcCtD
Alendronate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00136	0.00154	CcSEcCtD
Alendronate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00135	0.00153	CcSEcCtD
Alendronate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.00153	CcSEcCtD
Alendronate—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00135	0.00153	CcSEcCtD
Alendronate—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00152	CcSEcCtD
Alendronate—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00152	CcSEcCtD
Alendronate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00133	0.00151	CcSEcCtD
Alendronate—Infection—Vincristine—peripheral nervous system neoplasm	0.00133	0.00151	CcSEcCtD
Alendronate—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00133	0.0015	CcSEcCtD
Alendronate—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00149	CcSEcCtD
Alendronate—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00149	CcSEcCtD
Alendronate—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00148	CcSEcCtD
Alendronate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00131	0.00148	CcSEcCtD
Alendronate—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.00148	CcSEcCtD
Alendronate—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.0013	0.00147	CcSEcCtD
Alendronate—Asthenia—Melphalan—peripheral nervous system neoplasm	0.0013	0.00147	CcSEcCtD
Alendronate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0013	0.00147	CcSEcCtD
Alendronate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.00147	CcSEcCtD
Alendronate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00128	0.00145	CcSEcCtD
Alendronate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00128	0.00145	CcSEcCtD
Alendronate—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00128	0.00145	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00143	CcSEcCtD
Alendronate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00126	0.00143	CcSEcCtD
Alendronate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00142	CcSEcCtD
Alendronate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00142	CcSEcCtD
Alendronate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00124	0.0014	CcSEcCtD
Alendronate—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00123	0.0014	CcSEcCtD
Alendronate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00123	0.0014	CcSEcCtD
Alendronate—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00123	0.0014	CcSEcCtD
Alendronate—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00123	0.00139	CcSEcCtD
Alendronate—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00123	0.00139	CcSEcCtD
Alendronate—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00138	CcSEcCtD
Alendronate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00122	0.00138	CcSEcCtD
Alendronate—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00138	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00122	0.00138	CcSEcCtD
Alendronate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00137	CcSEcCtD
Alendronate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00137	CcSEcCtD
Alendronate—Malaise—Etoposide—peripheral nervous system neoplasm	0.0012	0.00136	CcSEcCtD
Alendronate—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00119	0.00135	CcSEcCtD
Alendronate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00135	CcSEcCtD
Alendronate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00135	CcSEcCtD
Alendronate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00134	CcSEcCtD
Alendronate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00134	CcSEcCtD
Alendronate—Infection—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00133	CcSEcCtD
Alendronate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00117	0.00133	CcSEcCtD
Alendronate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00132	CcSEcCtD
Alendronate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00132	CcSEcCtD
Alendronate—Rash—Topotecan—peripheral nervous system neoplasm	0.00117	0.00132	CcSEcCtD
Alendronate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00116	0.00132	CcSEcCtD
Alendronate—Headache—Topotecan—peripheral nervous system neoplasm	0.00116	0.00131	CcSEcCtD
Alendronate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00131	CcSEcCtD
Alendronate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00131	CcSEcCtD
Alendronate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00131	CcSEcCtD
Alendronate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00131	CcSEcCtD
Alendronate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00115	0.0013	CcSEcCtD
Alendronate—Headache—Tretinoin—peripheral nervous system neoplasm	0.00115	0.0013	CcSEcCtD
Alendronate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.0013	CcSEcCtD
Alendronate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.0013	CcSEcCtD
Alendronate—Pain—Vincristine—peripheral nervous system neoplasm	0.00114	0.0013	CcSEcCtD
Alendronate—Constipation—Vincristine—peripheral nervous system neoplasm	0.00114	0.0013	CcSEcCtD
Alendronate—Rash—Melphalan—peripheral nervous system neoplasm	0.00114	0.00129	CcSEcCtD
Alendronate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00114	0.00129	CcSEcCtD
Alendronate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00129	CcSEcCtD
Alendronate—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00128	CcSEcCtD
Alendronate—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00113	0.00128	CcSEcCtD
Alendronate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00112	0.00127	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00126	CcSEcCtD
Alendronate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00125	CcSEcCtD
Alendronate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00125	CcSEcCtD
Alendronate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00124	CcSEcCtD
Alendronate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00124	CcSEcCtD
Alendronate—Nausea—Topotecan—peripheral nervous system neoplasm	0.0011	0.00124	CcSEcCtD
Alendronate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00109	0.00124	CcSEcCtD
Alendronate—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00124	CcSEcCtD
Alendronate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00123	CcSEcCtD
Alendronate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00123	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00122	CcSEcCtD
Alendronate—Infection—Etoposide—peripheral nervous system neoplasm	0.00108	0.00122	CcSEcCtD
Alendronate—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00122	CcSEcCtD
Alendronate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00122	CcSEcCtD
Alendronate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00107	0.00122	CcSEcCtD
Alendronate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00121	CcSEcCtD
Alendronate—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00121	CcSEcCtD
Alendronate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00106	0.0012	CcSEcCtD
Alendronate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00106	0.0012	CcSEcCtD
Alendronate—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00119	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00117	CcSEcCtD
Alendronate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00116	CcSEcCtD
Alendronate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00116	CcSEcCtD
Alendronate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00115	CcSEcCtD
Alendronate—Pain—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00115	CcSEcCtD
Alendronate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000997	0.00113	CcSEcCtD
Alendronate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000996	0.00113	CcSEcCtD
Alendronate—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000989	0.00112	CcSEcCtD
Alendronate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000989	0.00112	CcSEcCtD
Alendronate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000986	0.00112	CcSEcCtD
Alendronate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000983	0.00111	CcSEcCtD
Alendronate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000976	0.0011	CcSEcCtD
Alendronate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000975	0.0011	CcSEcCtD
Alendronate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00096	0.00109	CcSEcCtD
Alendronate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000953	0.00108	CcSEcCtD
Alendronate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00095	0.00108	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000945	0.00107	CcSEcCtD
Alendronate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000945	0.00107	CcSEcCtD
Alendronate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000936	0.00106	CcSEcCtD
Alendronate—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000929	0.00105	CcSEcCtD
Alendronate—Pain—Etoposide—peripheral nervous system neoplasm	0.000927	0.00105	CcSEcCtD
Alendronate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000927	0.00105	CcSEcCtD
Alendronate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000919	0.00104	CcSEcCtD
Alendronate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000916	0.00104	CcSEcCtD
Alendronate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000903	0.00102	CcSEcCtD
Alendronate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000894	0.00101	CcSEcCtD
Alendronate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00089	0.00101	CcSEcCtD
Alendronate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000887	0.001	CcSEcCtD
Alendronate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000885	0.001	CcSEcCtD
Alendronate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000883	0.001	CcSEcCtD
Alendronate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000876	0.000992	CcSEcCtD
Alendronate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000875	0.000991	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000874	0.00099	CcSEcCtD
Alendronate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000872	0.000987	CcSEcCtD
Alendronate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00087	0.000985	CcSEcCtD
Alendronate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000861	0.000975	CcSEcCtD
Alendronate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00086	0.000974	CcSEcCtD
Alendronate—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00086	0.000973	CcSEcCtD
Alendronate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000857	0.000971	CcSEcCtD
Alendronate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000857	0.000971	CcSEcCtD
Alendronate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000856	0.000969	CcSEcCtD
Alendronate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000851	0.000964	CcSEcCtD
Alendronate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000849	0.000962	CcSEcCtD
Alendronate—Rash—Vincristine—peripheral nervous system neoplasm	0.000844	0.000956	CcSEcCtD
Alendronate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000843	0.000955	CcSEcCtD
Alendronate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000843	0.000954	CcSEcCtD
Alendronate—Headache—Vincristine—peripheral nervous system neoplasm	0.000839	0.00095	CcSEcCtD
Alendronate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000825	0.000934	CcSEcCtD
Alendronate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00081	0.000917	CcSEcCtD
Alendronate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000809	0.000916	CcSEcCtD
Alendronate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000799	0.000905	CcSEcCtD
Alendronate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.000901	CcSEcCtD
Alendronate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000795	0.0009	CcSEcCtD
Alendronate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.000896	CcSEcCtD
Alendronate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.000883	CcSEcCtD
Alendronate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000778	0.000881	CcSEcCtD
Alendronate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000767	0.000869	CcSEcCtD
Alendronate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000756	0.000856	CcSEcCtD
Alendronate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000753	0.000852	CcSEcCtD
Alendronate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000748	0.000848	CcSEcCtD
Alendronate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000746	0.000845	CcSEcCtD
Alendronate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000746	0.000844	CcSEcCtD
Alendronate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000745	0.000843	CcSEcCtD
Alendronate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000742	0.00084	CcSEcCtD
Alendronate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000734	0.000831	CcSEcCtD
Alendronate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000729	0.000826	CcSEcCtD
Alendronate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000717	0.000812	CcSEcCtD
Alendronate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000716	0.000811	CcSEcCtD
Alendronate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000703	0.000796	CcSEcCtD
Alendronate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.000792	CcSEcCtD
Alendronate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000691	0.000782	CcSEcCtD
Alendronate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000689	0.000781	CcSEcCtD
Alendronate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000689	0.00078	CcSEcCtD
Alendronate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000688	0.000779	CcSEcCtD
Alendronate—Rash—Etoposide—peripheral nervous system neoplasm	0.000684	0.000774	CcSEcCtD
Alendronate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000683	0.000773	CcSEcCtD
Alendronate—Headache—Etoposide—peripheral nervous system neoplasm	0.000679	0.000769	CcSEcCtD
Alendronate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000769	CcSEcCtD
Alendronate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.000764	CcSEcCtD
Alendronate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000672	0.000761	CcSEcCtD
Alendronate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000669	0.000758	CcSEcCtD
Alendronate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.00075	CcSEcCtD
Alendronate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000644	0.000729	CcSEcCtD
Alendronate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.000724	CcSEcCtD
Alendronate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000637	0.000721	CcSEcCtD
Alendronate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000634	0.000718	CcSEcCtD
Alendronate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000634	0.000718	CcSEcCtD
Alendronate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000626	0.000709	CcSEcCtD
Alendronate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000621	0.000704	CcSEcCtD
Alendronate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000619	0.000701	CcSEcCtD
Alendronate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000684	CcSEcCtD
Alendronate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000587	0.000664	CcSEcCtD
Alendronate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000587	0.000664	CcSEcCtD
Alendronate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.000656	CcSEcCtD
Alendronate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000633	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000627	CcSEcCtD
Alendronate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000606	CcSEcCtD
Alendronate—Pain—Epirubicin—peripheral nervous system neoplasm	0.00052	0.000589	CcSEcCtD
Alendronate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00052	0.000589	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.00058	CcSEcCtD
Alendronate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000567	CcSEcCtD
Alendronate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000563	CcSEcCtD
Alendronate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000561	CcSEcCtD
Alendronate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000547	CcSEcCtD
Alendronate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.000545	CcSEcCtD
Alendronate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.000545	CcSEcCtD
Alendronate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00048	0.000544	CcSEcCtD
Alendronate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00048	0.000544	CcSEcCtD
Alendronate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000525	CcSEcCtD
Alendronate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000521	CcSEcCtD
Alendronate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000507	CcSEcCtD
Alendronate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000506	CcSEcCtD
Alendronate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000503	CcSEcCtD
Alendronate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000503	CcSEcCtD
Alendronate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000494	CcSEcCtD
Alendronate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00043	0.000487	CcSEcCtD
Alendronate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000471	CcSEcCtD
Alendronate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000469	CcSEcCtD
Alendronate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000457	CcSEcCtD
Alendronate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000455	CcSEcCtD
Alendronate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000451	CcSEcCtD
Alendronate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000438	CcSEcCtD
Alendronate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000436	CcSEcCtD
Alendronate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000434	CcSEcCtD
Alendronate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000434	CcSEcCtD
Alendronate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000431	CcSEcCtD
Alendronate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000421	CcSEcCtD
Alendronate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000409	CcSEcCtD
Alendronate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000405	CcSEcCtD
Alendronate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000402	CcSEcCtD
Alendronate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000401	CcSEcCtD
Alendronate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000399	CcSEcCtD
Alendronate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000378	CcSEcCtD
